Home / Japan / BrightPath Biotherapeutics Co.,Ltd.
BrightPath Biotherapeutics Co.,Ltd.
Short position disclosed on October 20, 2026.
2.10% of the capital sold short
1 disclosing fund
68 disclosures on record
Evolution of the disclosed total
0%2%4%6%8%
Aug 19Sep 4Sep 20Oct 6Oct 22
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Nomura International plc | 2.10% | new | October 20, 2026 |
Get the moves on BrightPath Biotherapeutics Co.,Ltd. by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 19, 2026 | Nomura International plc | 2.72% | |
| August 17, 2026 | Nomura International plc | 2.53% | |
| August 17, 2026 | JPM Securities Japan Co Ltd. | 1.37% | |
| August 17, 2026 | Barclays Capital Securities Ltd | 1.23% | |
| August 14, 2026 | Nomura International plc | 2.61% | |
| August 14, 2026 | Barclays Capital Securities Ltd | 1.44% | |
| August 14, 2026 | JPM Securities Japan Co Ltd. | 1.41% | |
| August 13, 2026 | Barclays Capital Securities Ltd | 1.59% | |
| August 13, 2026 | JPM Securities Japan Co Ltd. | 1.54% | |
| August 10, 2026 | JPM Securities Japan Co Ltd. | 1.61% | |
| August 7, 2026 | Nomura International plc | 2.57% | |
| August 6, 2026 | Nomura International plc | 2.60% | |
| August 5, 2026 | Nomura International plc | 2.53% | |
| August 5, 2026 | Barclays Capital Securities Ltd | 1.61% | |
| August 5, 2026 | Goldman Sachs International | 0.41% | |
| August 4, 2026 | Barclays Capital Securities Ltd | 1.76% | |
| August 4, 2026 | Goldman Sachs International | 0.66% | |
| August 3, 2026 | Barclays Capital Securities Ltd | 1.82% |
Download 68 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- Towa Corporation 15.53% of the capital sold short
- KLab Inc. 15.31% of the capital sold short
- ReYuu Japan Inc. 13.71% of the capital sold short
- Datasection Inc. 11.62% of the capital sold short
- INTERTRADE Co.,Ltd. 9.39% of the capital sold short
- ERTH Group Co.,Ltd. 9.27% of the capital sold short
- W-SCOPE Corporation 8.95% of the capital sold short
- Metaplanet Inc. 8.77% of the capital sold short
- Nissan Motor Co.,ltd. 8.76% of the capital sold short
- Skyfall Inc. 8.69% of the capital sold short
- QD Laser,Inc. 8.64% of the capital sold short
- Kitagawa Seiki Co.,ltd. 7.33% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, BrightPath Biotherapeutics Co.,Ltd., source JPX, data as at October 20, 2026, https://www.quivad.com/action/brightpath-biotherapeutics-co-ltd?page=2